Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.38
HRC's Cash to Debt is ranked higher than
58% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.30 vs. HRC: 0.38 )
HRC' s 10-Year Cash to Debt Range
Min: 0.13   Max: 2.32
Current: 0.38

0.13
2.32
Equity to Asset 0.56
HRC's Equity to Asset is ranked higher than
67% of the 303 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. HRC: 0.56 )
HRC' s 10-Year Equity to Asset Range
Min: 0.17   Max: 0.67
Current: 0.56

0.17
0.67
Interest Coverage 16.31
HRC's Interest Coverage is ranked higher than
66% of the 206 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.96 vs. HRC: 16.31 )
HRC' s 10-Year Interest Coverage Range
Min: 5.45   Max: 25.97
Current: 16.31

5.45
25.97
F-Score: 7
Z-Score: 5.39
M-Score: -3.01
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 8.23
HRC's Operating margin (%) is ranked higher than
72% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.78 vs. HRC: 8.23 )
HRC' s 10-Year Operating margin (%) Range
Min: -27.59   Max: 19.59
Current: 8.23

-27.59
19.59
Net-margin (%) 4.34
HRC's Net-margin (%) is ranked higher than
71% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.12 vs. HRC: 4.34 )
HRC' s 10-Year Net-margin (%) Range
Min: -29.2   Max: 17.17
Current: 4.34

-29.2
17.17
ROE (%) 8.58
HRC's ROE (%) is ranked higher than
76% of the 302 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.58 vs. HRC: 8.58 )
HRC' s 10-Year ROE (%) Range
Min: -66.47   Max: 19.55
Current: 8.58

-66.47
19.55
ROA (%) 4.80
HRC's ROA (%) is ranked higher than
76% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.35 vs. HRC: 4.80 )
HRC' s 10-Year ROA (%) Range
Min: -32.86   Max: 11.33
Current: 4.8

-32.86
11.33
ROC (Joel Greenblatt) (%) 26.22
HRC's ROC (Joel Greenblatt) (%) is ranked higher than
81% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.02 vs. HRC: 26.22 )
HRC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -72.43   Max: 78.67
Current: 26.22

-72.43
78.67
Revenue Growth (%) 7.30
HRC's Revenue Growth (%) is ranked higher than
77% of the 280 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.20 vs. HRC: 7.30 )
HRC' s 10-Year Revenue Growth (%) Range
Min: -9.2   Max: 8.9
Current: 7.3

-9.2
8.9
EBITDA Growth (%) -6.50
HRC's EBITDA Growth (%) is ranked higher than
62% of the 235 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.70 vs. HRC: -6.50 )
HRC' s 10-Year EBITDA Growth (%) Range
Min: -63.4   Max: 134.9
Current: -6.5

-63.4
134.9
EPS Growth (%) -4.10
HRC's EPS Growth (%) is ranked higher than
65% of the 236 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.10 vs. HRC: -4.10 )
HRC' s 10-Year EPS Growth (%) Range
Min: -27.8   Max: 28.9
Current: -4.1

-27.8
28.9
» HRC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

HRC Guru Trades in Q3 2013

Jim Simons 198,100 sh (New)
John Keeley 1,477,670 sh (+4.04%)
Steven Cohen Sold Out
Ken Fisher 1,845,754 sh (-0.17%)
Chuck Royce 520,170 sh (-56.06%)
David Dreman 175,487 sh (-72.01%)
Joel Greenblatt 7,885 sh (-93.27%)
» More
Q4 2013

HRC Guru Trades in Q4 2013

Steven Cohen 5,839 sh (New)
Paul Tudor Jones 14,900 sh (New)
Joel Greenblatt 337,497 sh (+4180.24%)
Jim Simons 404,700 sh (+104.29%)
David Dreman 200,886 sh (+14.47%)
John Keeley 1,505,250 sh (+1.87%)
Chuck Royce 524,270 sh (+0.79%)
Ken Fisher 1,819,309 sh (-1.43%)
» More
Q1 2014

HRC Guru Trades in Q1 2014

David Dreman 207,145 sh (+3.12%)
John Keeley 1,514,809 sh (+0.64%)
Chuck Royce 524,270 sh (unchged)
Jim Simons Sold Out
Steven Cohen Sold Out
Ken Fisher 1,755,284 sh (-3.52%)
Paul Tudor Jones 10,500 sh (-29.53%)
Joel Greenblatt 161,218 sh (-52.23%)
» More
Q2 2014

HRC Guru Trades in Q2 2014

Paul Tudor Jones 14,000 sh (+33.33%)
David Dreman 228,119 sh (+10.13%)
Chuck Royce 521,470 sh (-0.53%)
Ken Fisher 1,706,884 sh (-2.76%)
Joel Greenblatt 90,281 sh (-44%)
John Keeley 481,948 sh (-68.18%)
» More
» Details

Insider Trades

Latest Guru Trades with HRC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
John Keeley 2014-06-30 Reduce -68.18%0.68%$36.14 - $41.53 $ 43.8713%481948
Joel Greenblatt 2014-06-30 Reduce -44%0.04%$36.14 - $41.53 $ 43.8713%90281
Joel Greenblatt 2014-03-31 Reduce -52.23%0.17%$35.13 - $44.16 $ 43.8713%161218
Joel Greenblatt 2013-12-31 Add 4180.24%0.32%$36.52 - $42.24 $ 43.879%337497
David Dreman 2013-09-30 Reduce -72.01%0.47%$33.23 - $37.62 $ 43.8724%175487
Joel Greenblatt 2013-09-30 Reduce -93.27%0.16%$33.23 - $37.62 $ 43.8724%7885
Joel Greenblatt 2013-06-30 Add 118.38%0.09%$32.9 - $37.15 $ 43.8725%117121
Joel Greenblatt 2012-12-31 Reduce -55.8%0.16%$26.4 - $30.56 $ 43.8755%63553
David Dreman 2012-09-30 New Buy0.56%$25.36 - $32.15 $ 43.8752%766981
Joel Greenblatt 2012-09-30 Add 28.93%0.06%$25.36 - $32.15 $ 43.8752%143771
Joel Greenblatt 2012-06-30 Add 28.31%0.06%$28.41 - $33.95 $ 43.8741%111514
Joel Greenblatt 2012-03-31 Add 159.59%0.15%$29.82 - $35.96 $ 43.8738%86913
Ray Dalio 2011-12-31 Sold Out 0.0031%$29.33 - $35 $ 43.8736%0
Joel Greenblatt 2011-09-30 Add 63.4%0.06%$27.37 - $47.48 $ 43.8726%32068
Ray Dalio 2011-09-30 New Buy$27.37 - $47.48 $ 43.8728%7023
Joel Greenblatt 2011-06-30 New Buy0.13%$38.54 - $46.45 $ 43.870%19625
George Soros 2011-06-30 Sold Out $38.54 - $46.45 $ 43.870%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 36.40
HRC's P/E(ttm) is ranked higher than
74% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 34.10 vs. HRC: 36.40 )
HRC' s 10-Year P/E(ttm) Range
Min: 7.13   Max: 36.38
Current: 36.4

7.13
36.38
P/B 3.00
HRC's P/B is ranked higher than
72% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.17 vs. HRC: 3.00 )
HRC' s 10-Year P/B Range
Min: 0.58   Max: 3.97
Current: 3

0.58
3.97
P/S 1.60
HRC's P/S is ranked higher than
84% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.03 vs. HRC: 1.60 )
HRC' s 10-Year P/S Range
Min: 0.4   Max: 1.95
Current: 1.6

0.4
1.95
PFCF 15.20
HRC's PFCF is ranked higher than
95% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 127.16 vs. HRC: 15.20 )
HRC' s 10-Year PFCF Range
Min: 3.32   Max: 43.62
Current: 15.2

3.32
43.62
EV-to-EBIT 20.21
HRC's EV-to-EBIT is ranked higher than
80% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.10 vs. HRC: 20.21 )
HRC' s 10-Year EV-to-EBIT Range
Min: 5.6   Max: 27.6
Current: 20.21

5.6
27.6
Shiller P/E 135.70
HRC's Shiller P/E is ranked higher than
78% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. HRC: 135.70 )
HRC' s 10-Year Shiller P/E Range
Min: 4.44   Max: 205.83
Current: 135.7

4.44
205.83
Current Ratio 2.07
HRC's Current Ratio is ranked higher than
65% of the 238 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.92 vs. HRC: 2.07 )
HRC' s 10-Year Current Ratio Range
Min: 1.33   Max: 3.1
Current: 2.07

1.33
3.1
Quick Ratio 1.67
HRC's Quick Ratio is ranked higher than
68% of the 238 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.84 vs. HRC: 1.67 )
HRC' s 10-Year Quick Ratio Range
Min: 1.15   Max: 2.72
Current: 1.67

1.15
2.72

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.40
HRC's Dividend Yield is ranked higher than
52% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.35 vs. HRC: 1.40 )
HRC' s 10-Year Dividend Yield Range
Min: 0.89   Max: 6.05
Current: 1.4

0.89
6.05
Dividend Payout 0.48
HRC's Dividend Payout is ranked higher than
83% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. HRC: 0.48 )
HRC' s 10-Year Dividend Payout Range
Min: 0.11   Max: 5.65
Current: 0.48

0.11
5.65
Dividend growth (3y) 8.60
HRC's Dividend growth (3y) is ranked higher than
79% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.60 vs. HRC: 8.60 )
HRC' s 10-Year Dividend growth (3y) Range
Min: -28.8   Max: 10.5
Current: 8.6

-28.8
10.5
Yield on cost (5-Year) 1.81
HRC's Yield on cost (5-Year) is ranked higher than
63% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.39 vs. HRC: 1.81 )
HRC' s 10-Year Yield on cost (5-Year) Range
Min: 1.24   Max: 8.45
Current: 1.81

1.24
8.45
Share Buyback Rate 1.90
HRC's Share Buyback Rate is ranked higher than
92% of the 238 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.60 vs. HRC: 1.90 )
HRC' s 10-Year Share Buyback Rate Range
Min: 3   Max: -0.9
Current: 1.9

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 10.20
HRC's Price/Tangible Book is ranked higher than
65% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.22 vs. HRC: 10.20 )
HRC' s 10-Year Price/Tangible Book Range
Min: 1.47   Max: 10.33
Current: 10.2

1.47
10.33
Price/DCF (Projected) 1.21
HRC's Price/DCF (Projected) is ranked higher than
90% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.31 vs. HRC: 1.21 )
HRC' s 10-Year Price/DCF (Projected) Range
Min: 0.3   Max: 9.08
Current: 1.21

0.3
9.08
Price/Median PS Value 1.34
HRC's Price/Median PS Value is ranked higher than
62% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. HRC: 1.34 )
HRC' s 10-Year Price/Median PS Value Range
Min: 0.36   Max: 1.63
Current: 1.34

0.36
1.63
Price/Graham Number 4.00
HRC's Price/Graham Number is ranked higher than
78% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.07 vs. HRC: 4.00 )
HRC' s 10-Year Price/Graham Number Range
Min: 0.65   Max: 3.83
Current: 4

0.65
3.83
Earnings Yield (Greenblatt) 4.90
HRC's Earnings Yield (Greenblatt) is ranked higher than
71% of the 260 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. HRC: 4.90 )
HRC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.6   Max: 17.7
Current: 4.9

3.6
17.7
Forward Rate of Return (Yacktman) 4.70
HRC's Forward Rate of Return (Yacktman) is ranked higher than
76% of the 258 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.55 vs. HRC: 4.70 )
HRC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -21.6   Max: 28.6
Current: 4.7

-21.6
28.6

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:HB9.Germany
Hill-Rom Holdings, Inc. formerly known as Hillenbrand Industries, Inc. was incorporated on August 7, 1969 in the State of Indiana. The Company is a worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals and information technology solutions. The Company's comprehensive product and service offerings are used by health care providers across the health care continuum in hospitals, extended care facilities and home care settings worldwide, to enhance the safety and quality of patient care. The company operates in three segments namely North America, Surgical and Respiratory Care and International. The Company's innovative patient support systems include a variety of electrically adjustable and manual bed systems and integrated and non-integrated therapeutic surfaces for use in high, mid and low acuity settings. Surgical table accessories from its Allen Medical business include the FlexFrame device, which converts a standard operating room table into a surgical table for spine procedures. It rents and sells non-invasive therapeutic products and surfaces for a variety of acute and chronic medical conditions, including pulmonary, wound and bariatric conditions, primarily to acute, extended and home care customers. It provides peak-need rentals and health care provider asset management for a wide variety of moveable medical equipment, also known as MME, such as ventilators defibrillators, intravenous pumps, and patient monitoring equipment. The products under Patient Environment and Mobilization Solutions include mobility solutions, architectural products and health care furniture. Architectural products include headwalls and power columns, such as the intensive care architectural arm platform called the Latitude system and the Elements headwall system, which both enable medical gases, communication accessories and electrical services to be distributed in patient rooms. It develops and markets a variety of communications technologies and software solutions that are designed to improve patient safety, drive efficiency at the point of care, and integrate the health care enterprise. These products include its suite of clinical communication and productivity solutions, its NaviCare platform, patient safety and its NaviCare Nurse Call. Principal materials used in its products include carbon steel, aluminum, stainless steel, wood and laminates, petroleum based products, such as foams and plastics, and other materials. It delivers its products to customers through international service centers. Some of the competitors are Invacare Corporation, Stryker Corporation, Encompass Group, LLC, Span-America Medical Systems, Inc., Dukane Corporation etc. The Company designs, manufactures, installs and distributes me
» More Articles for HRC

Headlines

Articles On GuruFocus.com
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 21,029 Shares Dec 07 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 18,893 Shares Dec 03 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 20,005 Shares Nov 23 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 9,757 Shares Nov 16 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 33,670 Shares Nov 12 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 25,967 Shares Nov 08 2010 
Weekly CEO Buys Highlight: AOL Inc, Consolidated Graphics Inc, Saul Centers Inc, Hill-ROM Holdings, May 16 2010 
HILL-ROM HOLDINGS, INC. (HRC) CEO John J Greisch buys 30,000 Shares May 12 2010 
HILL-ROM HOLDINGS, INC. Reports Operating Results (10-Q) Feb 04 2010 
HILL ROM HOLDINGS INC Reports Operating Results (10-Q) May 05 2009 


More From Other Websites
CE Mark for Boston Scientific's Vercise in Essential Tremor Sep 17 2014
Hill-Rom Declares Fourth Quarter 2014 Dividend Sep 03 2014
Hill-Rom to Participate in the Morgan Stanley Global Healthcare Conference Aug 27 2014
Hill-Rom and GE Reach Settlement in Patent Infringement Lawsuit Aug 25 2014
HILL-ROM HOLDINGS, INC. Financials Aug 15 2014
HILL-ROM HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 07 2014
Q3 2014 Hill-Rom Holdings, Inc. Earnings Release - Before Market Open Aug 07 2014
Hill-Rom Reports Improved Fiscal Third Quarter Results; Updates Full-Year Guidance Aug 07 2014
Jay D. Miller, the President and CEO of IMRIS Inc. (IMRS), Interviews with The Wall Street... Aug 01 2014
Hill-Rom Completes Acquisition of Trumpf Medical Aug 01 2014
Hill-Rom Holdings, Inc. Hosts Fiscal 2014 Third Quarter Earnings Conference Call and Webcast Jul 10 2014
CFO Moves: Baxter International, Hill-Rom, AngloGold Ashanti Jul 07 2014
HILL-ROM HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jul 07 2014
Hill-Rom wins federal appeal over hospital monitor patents Jun 27 2014
Will This Analyst Upgrade Help Hill-Rom (HRC) Stock Today? Jun 26 2014
Electromed: Possible Catalyst For A Positive Re-Rating Jun 19 2014
Hill-Rom Holdings - Good Acquisition Of Trumpf Medical, Yet Overall Appeal Is Limited Jun 18 2014
HILL-ROM HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jun 16 2014
Hill-Rom TO ACQUIRE TRUMPF Medical for $250M in cash Jun 16 2014
Hill-Rom Announces Definitive Agreement To Acquire TRUMPF Medical Jun 16 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK